Equities research analysts at StockNews.com initiated coverage on shares of Veradigm (NASDAQ:MDRX – Get Free Report) in a research report issued on Friday. The brokerage set a “hold” rating on the software maker’s stock.
Separately, Stephens increased their price target on shares of Veradigm from $7.00 to $13.00 and gave the company an “equal weight” rating in a report on Friday, January 31st.
Get Our Latest Report on Veradigm
Veradigm Stock Down 1.2 %
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
See Also
- Five stocks we like better than Veradigm
- Stock Average Calculator
- J.B. Hunt Transport Overcorrects Into a Buying Opportunity
- 3 Small Caps With Big Return Potential
- AppLovin: Can Record Profits Overcome Market Skepticism?
- How is Compound Interest Calculated?
- MarketBeat Week in Review – 04/14 – 04/18
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.